Replies to post #17808 on Cytogenix (fka CYGX)

[Paulness]

Yes Chadman very good NEWS
Dr. Yin Chen, CytoGenix' Vice President and Chief Scientific Officer, commented, "The introduction of CY403 into the preclinical product development phase within three months after target discovery and validation demonstrates the true value of our gene silencing technology. We have the capability to move very efficiently from discovery to product candidate in a matter of a few months

[BigB]

I personally like.....

"Further studies will confirm these capabilities in animal and human trials," added Dr. Chen.

he sounds very confident doesn't he?